Skip to main content
SpringerLink
Log in
Book cover

Thrombolytic Therapy in Acute Ischemic Stroke II pp 229–238Cite as

Neuronal Protection and Recanalization Strategies: Is More Better?

  • Conference paper

  • 64 Accesses

Abstract

The very title of this section of the symposium, i.e., “Ancillary Therapy for Cerebrovascular Reperfusion,” underscores the prominent hopes and expectations that the stroke community has invested in thrombolytic therapy. Thrombolysis makes intuitive sense, is effective in other circulatory beds, and may result in dramatic clinical changes. Furthermore, it requires mobilization of emergency personnel which requires neurologists to depart from their traditional passive therapeutic attitude towards stroke.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Nimodipine Study Group (1992) Clinical trial of nimodipine in acute stroke. Stroke 23:3–8

    Article  Google Scholar 

  2. DeGraba T, Grotta J (1991) Ca++ influx an a predictor of neuronal damage after graded global ischemia. Stroke 22:140

    Google Scholar 

  3. DeGraba T, Hanson S, Ostrow P, Grotta J (1992) Calcium influx, histologic damage, and motor performance in rats treated with NBQX after focal ischemia. Neurology 42(Suppl III):361

    Google Scholar 

  4. Gotoh O, Mohammed A, McCullough J, Graham D, Harper A, Teasdale G (1986) Nimodipine and the hemodynamic and histopathologic consequences of middle cerebral artery occlusion in the rat.. J Cereb Blood Flow Metab 6:321–331

    Article  PubMed  CAS  Google Scholar 

  5. Grotta J, DeGraba T (1992) How fast must we start neuroprotective therapies after cerebral ischemia? Stroke 23:147

    Google Scholar 

  6. Grotta J, Pettigrew L, Reid C, Rosenbaum D, McCandless D, Rhoades H (1988) Studies on the efficacy and mechanism of action of a calcium blocker after global cerebral ischemia. Stroke 19:447–454

    Article  PubMed  CAS  Google Scholar 

  7. Grotta J, Picone C, Dedman J, et al (1990) Neuronal protection correlates with prevention of calcium-caimodulin binding. Stroke 21(Suppl III):28–31

    Google Scholar 

  8. Grotta J, Picone C, Earls R, Strong R, Yao L, Dedman J (1990) Calcium-calmodulin binding in ischemic rat neurons after calcium channel blocker therapy. Stroke 21:948–952

    Article  PubMed  CAS  Google Scholar 

  9. Grotta J, Picone C, Ostrow P, et al (1990) CGS 19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia. Ann Neurol 27:612–619

    Article  PubMed  CAS  Google Scholar 

  10. Hewitt K, Corbett D (1992) Combined treatment with MK-801 and nicardipine reduces global ischemic damage in the gerbil. Stroke 23:82–86

    Article  PubMed  CAS  Google Scholar 

  11. International Nimodipine Study Group (1992) Meta-analysis of nimodipine trials in acute ischemic stroke. Stroke 23:148

    Google Scholar 

  12. Jacewicz M, Brint S, Tanabe J, Pulsinelli A (1990) Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal cerebral ischemia. J Cereb Blood Flow Metab 10:89–96

    Article  PubMed  CAS  Google Scholar 

  13. Olney J, Labruyere J, Price M (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360

    Article  PubMed  CAS  Google Scholar 

  14. Park C, Nehls D, Graham D (1988) Focal cerebral ischemia in the cat: Treatment with the glutamate antagonist MK-801 after induction of ischemia. J Cereb Blood Flow Metab 8:757

    Article  PubMed  CAS  Google Scholar 

  15. Picone C, Grotta J, Earls R, Strong R, Dedman J (1989) Immunohistochemical determination of calcium-calmodulin binding predicts neuronal damage after global ischemia. J Cereb Blood Flow Metab 9:805–811

    Article  PubMed  CAS  Google Scholar 

  16. Pulsinelli W, Brierley J, Plum F (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491–498

    Article  PubMed  CAS  Google Scholar 

  17. Rosenbaum D, Zabramski J, Frey J, et al (1991) Early treatment of ischemic stroke with a calcium antagonist. Stroke 22:437–441

    Article  PubMed  CAS  Google Scholar 

  18. Sharp F, Jasper P, Butman M (1992) Haloperidol prevents induction of HSP72 heat shock protein in posterior cingulate neurons injured by MK801, ketamine, and PCP: Implications for stroke therapy and psychosis. Neurology 42(Suppl III):360

    Google Scholar 

  19. Sheardown M, Nielsen E, Hansen A, Jacobsen P, Honore T (1990) 2, 3-dihydroxy-6-nitro-7-sylfamoyl-benzo (F) quinoxaline: A neuroprotectant for cerebral ischemia. Science 247:571–574

    Article  PubMed  CAS  Google Scholar 

  20. Steinberg G, Bell T (1991) Clinical dose-escalation safety study of the NMDA antagonist, dextromethorphan in neurosurgical patients. Stroke 22:141

    Google Scholar 

  21. Uematsu D, Araki N, Greenberg JH, Sladky J, Reivich M (1991) Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage. Neurology 41:88–94

    PubMed  CAS  Google Scholar 

  22. Zivin J, Mazzarella V (1991) Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch Neurol 48:1235–1238

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Texas Medical School, Houston, TX, USA

    J. Grotta

Authors
  1. J. Grotta
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Molecular and Experimental Medicine, The Scripps Research Institute and Division of Hematology/Medical Oncology, Scripps Clinic and Research Foundation, 10666 North Torrey Pines Road, La Jolla, CA, 92037, USA

    Gregory J. del Zoppo M.D.

  2. Neurology Service, Hyogo Brain and Heart Center at Himeji, 520 Saisho-ko, Himeji, 670, Japan

    Etsuro Mori M.D.

  3. Neurologische Klinik, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 400, W-6900, Heidelberg 1, Germany

    Werner Hacke

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Grotta, J. (1993). Neuronal Protection and Recanalization Strategies: Is More Better?. In: del Zoppo, G.J., Mori, E., Hacke, W. (eds) Thrombolytic Therapy in Acute Ischemic Stroke II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78061-5_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78061-5_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56442-3

  • Online ISBN: 978-3-642-78061-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation